hyperglycemic clamp
Showing 1 - 25 of 679
Metabolic Disease Trial in Boston (Hyperglycemic Clamp, Kisspeptin-10, Placebo)
Recruiting
- Metabolic Disease
- Hyperglycemic Clamp
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Jul 12, 2022
Type1 Diabetes Trial (Oral glucose tolerance test (OGTT), Hyperglycemic clamp test, Continuous glucose monitoring)
Not yet recruiting
- Type1 Diabetes Mellitus
- Oral glucose tolerance test (OGTT)
- +2 more
- (no location specified)
Mar 8, 2023
Healthy Volunteers Trial in Baltimore (Nabllone, CP-945,598, Hypoglycemic Clamp)
Completed
- Healthy Volunteers
- Nabilone
- +3 more
-
Baltimore, MarylandNational Institute of Aging, Clinical Research Unit
Jan 18, 2023
Hyperglycemia Trial in New Haven (Brain MRS during hyperglycemic clamp, Analysis of Metabolites in cerebrospinal fluid)
Completed
- Hyperglycemia
- Brain MRS during hyperglycemic clamp
- Analysis of Metabolites in cerebrospinal fluid
-
New Haven, ConnecticutYale University
Aug 15, 2022
Type2diabetes Trial in Rochester (Caloric Restriction, Hyperglycemic clamp)
Not yet recruiting
- Type2diabetes
- Caloric Restriction
- Hyperglycemic clamp
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 11, 2022
Cause for Post-Transplant Diabetes Mellitus After Allogeneic
Recruiting
- Diabetes Mellitus
- Cancer
- Oral Glucose Tolerance Test (OGTT)
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 10, 2022
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
Active, not recruiting
- IGT - Impaired Glucose Tolerance
- T2D
- Oral Glucose Tolerance Test
- +3 more
-
New Haven, ConnecticutYale University
Feb 8, 2022
Type2 Diabetes, Obesity, Morbid Trial in Hvidovre (Oral Glucose Tolerance Test, Hyperglycemic clamp with infusion of saline,
Completed
- Type2 Diabetes
- Obesity, Morbid
- Oral Glucose Tolerance Test
- Hyperglycemic clamp with infusion of saline, GLP-1 or GIP
-
Hvidovre, DenmarkHvidovre University Hospital
Mar 14, 2022
Type1diabetes, Depressive Symptoms, MDD Trial (Glucose Clamp)
Completed
- Type1diabetes
- +2 more
- Glucose Clamp
- (no location specified)
Apr 29, 2022
Hypoglycemia and Cardiac Arrhythmias in Type 1 Diabetes
Active, not recruiting
- Diabetes type1
- +2 more
- Hypoglycemic combined with either normo or hyperglycemic clamp.
-
Copenhagen, DenmarkClinical Metabolic Physiology, SDCC
Sep 1, 2021
Diabetes Trial in Beijing (Berberine Chloride, Placebo)
Completed
- Diabetes Mellitus
- Berberine Chloride
- Placebo
-
Beijing, Beijing, ChinaBeijing Tongren Hospital, Capital Medical University
Feb 21, 2020
Hypercholesterolemia, Insulin Resistance, Insulin Secretion Trial in Tuebingen (Lowering cholesterol concentrations by PCSK-9
Recruiting
- Hypercholesterolemia
- +2 more
- Lowering cholesterol concentrations by PCSK-9 inhibitor
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Aug 24, 2022
Maturity-Onset Diabetes of the Young, Type 3, Type 2 Diabetes Trial in Herlev (Hyperglycaemic clamp, Placebo, Empagliflozin)
Recruiting
- Maturity-Onset Diabetes of the Young, Type 3
- Type 2 Diabetes
- Hyperglycaemic clamp
- +2 more
-
Herlev, DenmarkSteno Diabetes Center Copenhagen
Jun 24, 2022
Spinal Cord Stimulation, Insulin Secretion Trial in Tuebingen (BurstDR stimulation, Tonic stimulation, No stimulation)
Recruiting
- Spinal Cord Stimulation
- Insulin Secretion
- BurstDR stimulation
- +2 more
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Apr 3, 2023
Insulin Secretion Trial in Durham (GIP infusion, GLP-1 infusion, Ex-9 infusion)
Suspended
- Insulin Secretion
- GIP infusion
- +2 more
-
Durham, North CarolinaDuke Center for Living
Sep 12, 2022
Type 2 Diabetes, Obesity, Pediatric Obesity Trial in Jacksonville (Hyperglycemic clamp, Hyperinsulinemic Euglycemic clamp)
Completed
- Type 2 Diabetes Mellitus
- +5 more
- Hyperglycemic clamp
- Hyperinsulinemic Euglycemic clamp
-
Jacksonville, FloridaNemours Children's Health System
Sep 5, 2019
Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome
Withdrawn
- McCune-Albright Syndrome
- +3 more
- Hyperinsulinemic Euglycemic Clamp and 2H20
- +2 more
-
New Haven, ConnecticutYale New Haven Hospital
Aug 30, 2019
ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation
Not yet recruiting
- Type 2 Diabetes
- Impaired Insulin Secretion
-
Tübingen, GermanyUniversity Hopsital Tübingen
Oct 11, 2022
Obesity, Type2diabetes, NAFLD Trial in Rochester (Glucagon response study)
Not yet recruiting
- Obesity
- +2 more
- Glucagon response study
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 11, 2022
Diabetes, Type 2 Trial in Hong Kong (Dorzagliatin, )
Completed
- Diabetes Mellitus, Type 2
- Dorzagliatin
- placebo
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Jul 19, 2022
Diabete Type 2 Trial in New Haven (Intensification of insulin regimen/Nutrition)
Suspended
- Diabete Type 2
- Intensification of insulin regimen/Nutrition
-
New Haven, ConnecticutYale New Haven Hospital
Jan 13, 2023
Diabetes, Type 2 Trial (Magnetic Resonance Spectroscopy Imaging (MRSI))
Not yet recruiting
- Diabetes Mellitus, Type 2
- Magnetic Resonance Spectroscopy Imaging (MRSI)
- (no location specified)
Mar 8, 2023
PreDiabetes, Impaired Glucose Tolerance, Obesity Trial in Columbus (Sacubitril-Valsartan Tab 97-103 MG, Valsartan 160mg, Placebo
Recruiting
- PreDiabetes
- +3 more
- Sacubitril-Valsartan Tab 97-103 MG
- +2 more
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Jul 21, 2022
Type 2 Diabetes Trial in Baltimore (euinsulinemic euglycemic glucose clamp, euinsulinemic hyperglycemic glucose clamp,
Completed
- Type 2 Diabetes
- euinsulinemic euglycemic glucose clamp
- +3 more
-
Baltimore, MarylandUniverisity of Maryland, Baltimore
Sep 10, 2019